BR0313740A - Derivados do ácido r(+)-2-amino-3-hidróxi-propanóico com ação glicinérgica - Google Patents

Derivados do ácido r(+)-2-amino-3-hidróxi-propanóico com ação glicinérgica

Info

Publication number
BR0313740A
BR0313740A BR0313740-6A BR0313740A BR0313740A BR 0313740 A BR0313740 A BR 0313740A BR 0313740 A BR0313740 A BR 0313740A BR 0313740 A BR0313740 A BR 0313740A
Authority
BR
Brazil
Prior art keywords
alkyl
amino
acid derivatives
hydroxy
alkenyl
Prior art date
Application number
BR0313740-6A
Other languages
English (en)
Inventor
Kathleen Clarence-Smith
Jean-Marie Georges Contreras
Laurence Nathalie Deyon
Camille Georges Wermuth
Original Assignee
Prestwick Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prestwick Pharmaceuticals Inc filed Critical Prestwick Pharmaceuticals Inc
Publication of BR0313740A publication Critical patent/BR0313740A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"'DERIVADOS DO áCIDO R(+)-2-AMINO-3-HIDRóXI-PROPANóICO COM AçãO GLICINéRGICA". Trata-se da utilização de derivados do ácido R(+)-2-amino-3-hidróxi-propanóico, substituído em nitrogênio por um grupo (C~ 1~-C~ 6~)alquila, (C~ 3~-C~ 6~)alquenilo, 3-oxo(C~ 5~-C~ 6~)alquila, 3-oxo(C~ 4~-C~ 6~)alquen-2-ilo, fenil(C~ 1~-C~ 6~)alquila, fenil(C~ 2~-C~ 6~)alquenilo, gem-difenil(C~ 1~-C~ 6~)alquila, gem-difenil(C~ 2~-C~ 6~)alquenilo, (C~ 1~-C~ 6~)alcanoílo, alanila opcionalmente N-substituída, lisinoíla opcionalmente N,N<39>dissubstituída, fenil(C~ 1~-C~ 6~)alquilideno ou gem-difenil(C~ 1~C~ 6~)alquilideno., e um de seus sais farmaceuticamente aceitáveis para a preparação de medicamentos destinados ao tratamento de doenças do sistema nervoso central decorrentes de uma transmissão glicinérgica reduzida, em especial, para o tratamento de autismo, esquizofrenia ou doença de Alzheimer.
BR0313740-6A 2002-08-14 2003-08-01 Derivados do ácido r(+)-2-amino-3-hidróxi-propanóico com ação glicinérgica BR0313740A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210306A FR2843590B1 (fr) 2002-08-14 2002-08-14 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
PCT/FR2003/002447 WO2004016580A2 (fr) 2002-08-14 2003-08-01 Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique

Publications (1)

Publication Number Publication Date
BR0313740A true BR0313740A (pt) 2005-07-19

Family

ID=30775996

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313740-6A BR0313740A (pt) 2002-08-14 2003-08-01 Derivados do ácido r(+)-2-amino-3-hidróxi-propanóico com ação glicinérgica

Country Status (19)

Country Link
US (1) US7488755B2 (pt)
EP (1) EP1529030A2 (pt)
JP (1) JP2005535715A (pt)
KR (2) KR100756138B1 (pt)
CN (1) CN1675169A (pt)
AU (1) AU2003274213B2 (pt)
BR (1) BR0313740A (pt)
CA (1) CA2497347A1 (pt)
CR (1) CR7736A (pt)
EA (1) EA010417B1 (pt)
FR (1) FR2843590B1 (pt)
GE (1) GEP20074194B (pt)
IL (1) IL166778A0 (pt)
MX (1) MXPA05001761A (pt)
NO (1) NO20050961L (pt)
NZ (1) NZ538633A (pt)
PL (1) PL375413A1 (pt)
UA (1) UA80559C2 (pt)
WO (1) WO2004016580A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013072936A2 (en) * 2011-11-10 2013-05-23 Ramamohan Rao Davuluri A novel process for the preparation of (r)-n-benzyl-2 acetamido-3-methoxypropionamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
US5332758A (en) * 1990-07-13 1994-07-26 Kanebo, Ltd. Collagen metabolism ameliorant and its use
ES2036926B1 (es) * 1991-08-08 1994-01-16 Uriach & Cia Sa J "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
GB9425730D0 (en) 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
PT871440E (pt) * 1995-12-07 2006-07-31 Daniel C Javitt Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
RU2219924C2 (ru) * 1998-04-14 2003-12-27 Дзе Дженерал Хоспитал Корпорейшн Способ лечения нейропсихиатрических расстройств
GB2410947B (en) 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
AU2003274213B2 (en) 2008-03-13
FR2843590A1 (fr) 2004-02-20
FR2843590B1 (fr) 2007-10-05
WO2004016580A2 (fr) 2004-02-26
KR100890674B1 (ko) 2009-03-26
GEP20074194B (en) 2007-09-10
UA80559C2 (en) 2007-10-10
US20050261372A1 (en) 2005-11-24
IL166778A0 (en) 2006-01-15
JP2005535715A (ja) 2005-11-24
KR20070067250A (ko) 2007-06-27
NZ538633A (en) 2007-10-26
AU2003274213A1 (en) 2004-03-03
WO2004016580A3 (fr) 2004-04-08
EA200500333A1 (ru) 2005-08-25
CN1675169A (zh) 2005-09-28
KR100756138B1 (ko) 2007-09-05
KR20050055697A (ko) 2005-06-13
EA010417B1 (ru) 2008-08-29
CA2497347A1 (en) 2004-02-26
US7488755B2 (en) 2009-02-10
CR7736A (es) 2008-10-10
PL375413A1 (en) 2005-11-28
MXPA05001761A (es) 2005-04-25
EP1529030A2 (fr) 2005-05-11
NO20050961L (no) 2005-04-28

Similar Documents

Publication Publication Date Title
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
BR9913288A (pt) Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
BR0112000A (pt) Amina, composto, álcool, epóxido, cetona, azida, composição, uso de uma amina, métodos de tratamento de um paciente, de inibição da atividade da beta-secretase, de clivagem da proteìna precursora de amilóide e da produção de peptìdeo amilóide e de placa beta-amilóide em um animal, de tratamento ou prevenção de uma doença distinguida por depósitos de beta-amilóide no cérebro e de produção de um complexo de beta-secretase, e, kit
BR0015624A (pt) Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas
BRPI0510515A (pt) compostos de morfolina
HUP0203325A2 (hu) Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BRPI0411295A (pt) compostos e seu uso na terapia
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
AR045004A1 (es) Composiciones farmaceuticas que comprenden 11-piperazin-1-ildibenzo[b,f][1,4]tiazepina
BR0111892A (pt) Bis-arilsulfonas
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
BR0111911A (pt) Preparados de ação prolongada de antibióticos de quinolona e processos para a sua preparação
BR9915646A (pt) Intermediários, processo para a preparação de agente antibiótico macrolìdeo a partir deles
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
BR0313740A (pt) Derivados do ácido r(+)-2-amino-3-hidróxi-propanóico com ação glicinérgica
EP3302493B1 (en) Inhibitors of cystine-glutamate transporter for use in treating or preventing substance-related and addictive disorders
GT200400068A (es) Derivados de 3-azabiciclo[3.2.1]octano
BR0112131A (pt) Composições farmacêuticas e métodos para uso
Wood et al. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes
BR9914418A (pt) Concentrado oral de sertralina
BRPI0417796A (pt) preparado efervescente de uma substáncia básica de efeito medicinal
BR0214731A (pt) Métodos de tratar ou prevenir mal de alzheimer em um indivìduo e uma doença evidenciada por depósitos beta-amilóides sobre ou dentro do cérebro, de tratar um indivìduo que possui, ou para prevenir que um indivìduo adquira, uma doença ou condição, de inibir atividade de beta-secretase, clivagem de um isótipo de protéina precursora de amilóide e produção de peptìdeo beta amilóide e de placa amilóde de um animal e de produzir um complexo de beta-secretase, uso de um composto e composição
BRPI0413750A (pt) uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit
BR0213634A (pt) Sistema de liberação de droga com ação retardada para um agente antiespasmódico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A E 5A ANUIDADES.

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: PARA QUE SEJA ACEITA A PETICAO 020110008376 DE 26/01/2011 APRESENTE PROCURACAO QUE ATRIBUA PODERES AO SIGNTARIO DA MESMA.

B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO 020110008376 DE 26/01/2011 EM VIRTUDE DO DISPOSTO NO ART. 216 C/C ART. 219,INCISO II DA LPI.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2077 DE 26/10/2010.